REQUIP Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Requip, and what generic alternatives are available?
Requip is a drug marketed by Glaxosmithkline Llc and is included in two NDAs.
The generic ingredient in REQUIP is ropinirole hydrochloride. There are fourteen drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the ropinirole hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Requip
A generic version of REQUIP was approved as ropinirole hydrochloride by PRINSTON INC on May 5th, 2008.
Summary for REQUIP
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 136 |
Clinical Trials: | 36 |
Patent Applications: | 1,647 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for REQUIP |
What excipients (inactive ingredients) are in REQUIP? | REQUIP excipients list |
DailyMed Link: | REQUIP at DailyMed |
Recent Clinical Trials for REQUIP
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Titan Pharmaceuticals | Phase 1/Phase 2 |
Vanderbilt University Medical Center | Phase 4 |
Seoul National University Hospital | Phase 4 |
Anatomical Therapeutic Chemical (ATC) Classes for REQUIP
Paragraph IV (Patent) Challenges for REQUIP
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
REQUIP | Tablets | ropinirole hydrochloride | 3 mg, 4 mg and 5 mg | 020658 | 1 | 2005-02-04 |
REQUIP | Tablets | ropinirole hydrochloride | 0.25 mg, 0.5 mg, 1 mg and 2 mg | 020658 | 1 | 2004-12-22 |
US Patents and Regulatory Information for REQUIP
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Glaxosmithkline Llc | REQUIP | ropinirole hydrochloride | TABLET;ORAL | 020658-001 | Sep 19, 1997 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Glaxosmithkline Llc | REQUIP | ropinirole hydrochloride | TABLET;ORAL | 020658-005 | Sep 19, 1997 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Glaxosmithkline Llc | REQUIP | ropinirole hydrochloride | TABLET;ORAL | 020658-004 | Sep 19, 1997 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for REQUIP
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Glaxosmithkline Llc | REQUIP | ropinirole hydrochloride | TABLET;ORAL | 020658-006 | Jan 27, 1999 | ⤷ Try a Trial | ⤷ Try a Trial |
Glaxosmithkline Llc | REQUIP | ropinirole hydrochloride | TABLET;ORAL | 020658-004 | Sep 19, 1997 | ⤷ Try a Trial | ⤷ Try a Trial |
Glaxosmithkline Llc | REQUIP | ropinirole hydrochloride | TABLET;ORAL | 020658-002 | Sep 19, 1997 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for REQUIP
See the table below for patents covering REQUIP around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Spain | 543593 | ⤷ Try a Trial | |
Algeria | 587 | 4-Aminoalkyl-2(3H) inolones. | ⤷ Try a Trial |
Denmark | 275488 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for REQUIP
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0299602 | C970006 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: ROPINIROLUM, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAA RDBAAR ZOUT, IN HET BIJZONDER HYDROCHLORIDE; NAT. REGISTRATION NO/DATE: RVG 20761 - RVG 20765 19961202; FIRST REGISTRATION: GB PL 10592/0085 19960702 |
0299602 | 97C0036 | Belgium | ⤷ Try a Trial | PRODUCT NAME: CHLORHYDRATE DE ROPINIROLE (=ROPINIROLE); NAT. REGISTRATION NO/DATE: 981 IS 120 F 3 19970414; FIRST REGISTRATION: GB PL 10592/0085 19960702 |
0113964 | 97C0037 | Belgium | ⤷ Try a Trial | PRODUCT NAME: OESTROGENES EQUINS CONJUGUES; ACETATE DE MEDROXYPROGESTERONE; NAT. REGISTRATION NO/DATE: NL 19569 19950301; FIRST REGISTRATION: CH - 52647 01 010 19940826 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |